Show simple item record

dc.contributor.authorJaeggi, T
dc.contributor.authorKortman, GA
dc.contributor.authorMoretti, D
dc.contributor.authorChassard, C
dc.contributor.authorHolding, P
dc.contributor.authorDostal, A
dc.contributor.authorBoekhorst, J
dc.contributor.authorTimmerman, HM
dc.contributor.authorSwinkels, DW
dc.contributor.authorTjalsma, H
dc.contributor.authorNjenga, J
dc.contributor.authorMwangi, A
dc.contributor.authorKvalsvig, J
dc.contributor.authorLacroix, C
dc.contributor.authorZimmermann, MB
dc.date.accessioned2014-12-18T15:37:56Z
dc.date.available2014-12-18T15:37:56Z
dc.date.issued2014
dc.identifier.citationGut. 2014 Aug 20. pii: gutjnl-2014en_US
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/pubmed/25143342
dc.identifier.urihttp://hdl.handle.net/11295/77982
dc.description.abstractBACKGROUND: In-home iron fortification for infants in developing countries is recommended for control of anaemia, but low absorption typically results in >80% of the iron passing into the colon. Iron is essential for growth and virulence of many pathogenic enterobacteria. We determined the effect of high and low dose in-home iron fortification on the infant gut microbiome and intestinal inflammation. METHODS: We performed two double-blind randomised controlled trials in 6-month-old Kenyan infants (n=115) consuming home-fortified maize porridge daily for 4 months. In the first, infants received a micronutrient powder (MNP) containing 2.5 mg iron as NaFeEDTA or the MNP without iron. In the second, they received a different MNP containing 12.5 mg iron as ferrous fumarate or the MNP without the iron. The primary outcome was gut microbiome composition analysed by 16S pyrosequencing and targeted real-time PCR (qPCR). Secondary outcomes included faecal calprotectin (marker of intestinal inflammation) and incidence of diarrhoea. We analysed the trials separately and combined. RESULTS: At baseline, 63% of the total microbial 16S rRNA could be assigned to Bifidobacteriaceae but there were high prevalences of pathogens, including Salmonella Clostridium difficile, Clostridium perfringens, and pathogenic Escherichia coli. Using pyrosequencing, +FeMNPs increased enterobacteria, particularly Escherichia/Shigella (p=0.048), the enterobacteria/bifidobacteria ratio (p=0.020), and Clostridium (p=0.030). Most of these effects were confirmed using qPCR; for example, +FeMNPs increased pathogenic E. coli strains (p=0.029). +FeMNPs also increased faecal calprotectin (p=0.002). During the trial, 27.3% of infants in +12.5 mgFeMNP required treatment for diarrhoea versus 8.3% in -12.5 mgFeMNP (p=0.092). There were no study-related serious adverse events in either group. CONCLUSIONS: In this setting, provision of iron-containing MNPs to weaning infants adversely affects the gut microbiome, increasing pathogen abundance and causing intestinal inflammation.en_US
dc.language.isoenen_US
dc.publisherUniversity of Nairobien_US
dc.titleIron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants.en_US
dc.typeArticleen_US
dc.type.materialenen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record